Claudin-2 downregulation by KSHV infection is involved in the regulation of endothelial barrier function

Journal of Cutaneous Pathology

Volumn 41, Issue 8, 2014, Pages 630-639

  Yan, Yutao ^a   Tan, Xiaohua ^a   Li, Dongmei ^b   Wang, Xiaobo ^a   Zeng, Yan ^b   Yang, Lei ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

barrier function; claudin 2; Kaposi sarcoma; Kaposi sarcoma associated herpes virus (KSHV)

Indexed keywords

CLAUDIN; CLDN2 PROTEIN, HUMAN; TRANSCRIPTOME;

BIOSYNTHESIS; CAPILLARY PERMEABILITY; CLUSTER ANALYSIS; COMPLICATION; DNA MICROARRAY; DOWN REGULATION; ENDOTHELIUM CELL; GENETICS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; METABOLISM; MIXED INFECTION; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CLAUDINS; CLUSTER ANALYSIS; COINFECTION; DOWN-REGULATION; ENDOTHELIAL CELLS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; TRANSCRIPTOME;

EID: 84905560420     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12332     Document Type: Article

References (42)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 226: 1865.
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM,. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186.
3. Greene W, Kuhne K, Ye F, et al. Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 2007; 133: 69.
4. Uldrick TS, Whitby D,. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett 2011; 205: 150.
5. Wang X, He B, Zhang Z, et al. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Virol J 2010; 7: 62.
6. Wang H, Liu j Dilimulati, et al. Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China. Virol J 2011; 8: 539.
7. Friborg J Jr, Kong W, Hottiger MO, Nabel GJ,. P53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999; 402: 889.
8. Radkov SA, Kellam P, Boshoff C,. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000; 6: 1121.
9. Sullican R, Dezube BJ, Koon HB,. Signal transduction targets in Kaposi's sarcoma. Curr Opin Oncol 2006; 18: 456.
10. Sodhi A, Montaner S, Gutkind JS,. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? FASEB J 2004; 18: 422.
11. Field N, Low W, Daniels M, et al. KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 2003; 116 (Pt 18): 3721.
12. Sun Q, Zachariah S, Chaudhary PM,. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J Biol Chem 2003; 278: 52437.
13. Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ,. HIV-associated multicentric Castleman's disease. Am J Hematol 2008; 83: 498.
14. Dezube BJ,. Clinical presentation and natural history of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am 1996; 10: 1023.
15. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B,. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 1987; 317: 1297.
16. Su MW, Lin HM, Yuan HS, Chu WC,. Categorising host-dependent RNA viruses by principal component analysis of their codon usage preferences. J Comput Biol 2009; 16: 1539.
17. Fang K, Bruce M, Pattillo CB, et al. Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Phsiol Genomics 2011; 43: 43.
18. Yan Y, Dalmasso G, Nguyen HT, et al. Nuclear factor-kappaB is a critical mediator of Ste20-like proline/alanine-rich kinase regulation in intestinal inflammation. Am J Pathol 2008; 173: 1013.
19. Yan Y, Nguyen H, Dalmasso G, Sitaraman SV, Merlin D,. Cloning and characterization of a new intestinal inflammation-associated colonic epithelial Ste20-related protein kinase isoform. Biochim Boiphys Acta 2007; 1769: 106.
20. Bazzoni G, Dejana E,. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostatis. Physiol Rev 2004; 84: 869.
21. Madara JL,. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 1990; 116: 177.
22. Briand V, Watier L, LE Hesran JY, Garcia A, Cot M,. Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children? Am J Trop Med Hyg 2005; 72: 702.
23. Hagel I, Cabrera M, Puccio F, et al. Co-infection with Ascaris lumbricoides modulates protective immunereponses against Giardia duodenalis in school Venezuelan rural children. Acta Trop 2011; 117: 189.
24. Rezaee SA, Cunnigham C, Davison AJ, Blackbourn DJ,. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol 2006; 87 (Pt 7): 1781.
25. Bahbouhi B, Landay A, Al-Harthi L,. Dynamics of cytokine expression in HIV productively infected primary CD4+ T cells. Blood 2004; 103: 4581.
26. Anderson JM, Van Itallie CM,. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 2009; 1: a002584.
27. Kotler BM, Kerstetter JE, Insogna KL,. Claudins, dietary milk proteins, and intestinal barrier regulation. Nutr Rev 2013; 71: 60.
28. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N,. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 1997; 136: 1239.
29. Ruffer C, Gerke V,. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol 2004; 83: 135.
30. Mazzon E, Cuzzocrea S,. Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation. Respir Res 2007; 8: 75.
31. Yan Y, Laroui H, Ingersoll SA, et al. Overexpression of Ste20-related proline/alanine-rich kinase exacerbates experimental colitis in mice. J Immunol 2011; 187: 1496.
32. Abbott NJ,. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mil Neurobiol 2000; 20: 131.
33. Stamatovic SM, Keep RF, Andjelkovic AV,. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol 2008; 6: 179.
34. Sydora BC, Macfarlane SM, Walker JW, et al. Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse. Inflamm Bowel Dis 2007; 13: 947.
35. Roux KJ, Amici SA, Fletcher BS, Notterpek L,. Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22. Mol Biol Cell 2005; 16: 1142.
36. Wong V, Gumbiner BM,. A synthetic peptide corresponding to the extracellular domain of occluding perturbs the tight junction permeability barrier. J Cell Biol 1997; 136: 399.
37. Halbleib JM, Nelson WJ,. Cadherins indevelopment: cell adhesion, sorting, and tissue morphogenesis. Genes Dev 2006; 20: 3199.
38. Taddei A, Giampietro C, Conti A, et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 2008; 10: 923.
39. Guilluy C, Zhang Z, Bhende PM, et al. Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood 2011; 118: 5344.
40. Ma T, Jham BC, Hu J, et al. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Proc Batl Acad Sci USA 2010; 107: 14363.
41. Morrell CN, Srivastava K, Swaim A, et al. Beta interferon supresses the development of experimental cerebral malaria. Infect Immun 2011; 78: 1750.
42. Zhng Y, Viennois E, Xiao B, et al. Knockout of Ste20-like proline/alanine-rich kinase (SPAK) attenuates intestinal inflammation in mice. Am J Pathol 2013; 182: 1617.